Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Open-market buy Director bought 2,982 shares at an average $2.98 ($8,881)
  2. 4 Open-market buy Director bought 882 shares at an average $2.98 ($2,627)
  3. 4 Open-market buy Director bought 1,785 shares at an average $2.98 ($5,316)
  4. 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,205 shares at an average $2.98 ($6,567)
  5. 4 Open-market buy Director bought 1,785 shares at an average $3.26 ($5,827)
  6. 4 Open-market buy Director bought 2,414 shares at an average $3.32 ($8,005)
  7. 4 Open-market buy Director bought 714 shares at an average $3.32 ($2,368)
  8. 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,310 shares at an average $3.25 ($7,505)
  9. 4 Grant or award Director acquired 2,040 shares (grant or award)
  10. 4 Open-market buy Sr VP/Chief Commercial Officer bought 3,150 shares at an average $3.01 ($9,495)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Director acquired 1,000 shares (grant or award)
  13. 4 Grant or award Director acquired 1,000 shares (grant or award)
  14. 4 Grant or award Director acquired 5,000 shares (grant or award)
  15. 4 Grant or award Director acquired 1,000 shares (grant or award)
  16. 4 Grant or award Director acquired 1,000 shares (grant or award)
  17. 4 Grant or award Director acquired 3,465 shares (grant or award)
  18. 4 Shares withheld for taxes Chairman and CEO gave up 37,350 shares (to pay taxes)
  19. 4 Shares withheld for taxes VP and Chief Compliance Office gave up 2,560 shares (to pay taxes)
  20. 4 Shares withheld for taxes SVP and Chief Development Off. gave up 2,870 shares (to pay taxes)

Page 12 of 26 · 512 filings